AxoGen, Inc. (AXGN) PT Raised to $50 at Citizens on Q1 Results - Record sales, High Growth
Tweet Send to a Friend
Citizens analyst David Turkaly raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $50.00 (from $42.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
